SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (3246)3/1/2014 5:19:00 PM
From: Zohar_Power  Read Replies (1) | Respond to of 4474
 
Not the point I was making, Tom

"dirty" would mean that the drug is contaminated, adulterated or impure, and the drug is none of these.
The company would not release a drug that does not meet GMP requirements.

It's a poor choice of a word and misleading, if not purposely inflamatory. If the author had concerns about the drug's efficacy or safety he could have said so without using that term.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News